•  

     

    NEWS

    The most relevant news about our Group, in Argentina and around the world.

Argentine genetics arriving in China to improve their meat

Garruchos Agropecuaria Group Insud has signed a technology transfer agreement with the Asian firm Shenlong to improve the meat quality of the Asian country. Argentine genetics, a step forward.

Garruchos Agropecuaria, through its hut Los Murmullos, became the first Argentine company to export frozen embryos to genetics genetics Aberdeen Angus, a meat-producing breed. This was the first step in a technology transfer agreement that included the construction of a gene center in Yinchuan, capital of Ningxia province, in conjunction with Chinese firm Shenlong. Both companies, Shenlong and Garruchos Agropecuaria, were associated under the name Garruchos China with the aim of contributing to the genetic improvement of Chinese cattle, from selected embryos, exported from our country.

“China needs to increase its meat production and the quality of its livestock. After several visits to Argentina, we were chosen to lead this project which has two very positive aspects: the export of high added value products and the training of human resources by Argentine specialists in bovine genetics” said Hugo Sigman, head of Cabaña Los Murmullos and CEO of Grupo Insud.

The genetic center will have an area of ​​30 hectares, will mean an investment of US $ 10 million, and will be ready in 2019. The cooperation project began in 2015 with a first export of 1,000 Angus frozen embryos from Los Murmullos, aimed at improving the Meat production of the Asian country. Since then, the cottage has also shipped 15,000 doses of brood semen.

(Español) Ver nota completa

Top Story

News

Algunas aclaraciones sobre la vacuna | Hugo Sigman

Por Hugo Sigman En momentos en que la segunda ola de Covid se cobra más y más muertos, con muchas familias perdiendo a sus seres queridos y el sistema de salud muy estresado, la intoxicación de noticias falsas sólo contribuye … Continue reading

+

Latest News

News Mabxience

Hugo Sigman, sobre la vacuna de AstraZeneca: “Confiamos en que las pruebas serán exitosas”

+

News Grupo Insud Mundo Sano

El futuro de la pandemia visto por la bioquímica Silvia Gold: “Mucho de lo que aprendimos con dengue, creemos que es lo que hay que hacer con COVID-19″

+

News Grupo Insud

Hugo Sigman: “El único negocio que tengo con el Estado representa el 1,5% de mi facturación”

+

News Top Story Grupo Insud

Silvia Gold: “Las vacunas que más esperanza nos generan son las de vector viral”

+

News Top Story Mabxience

mAbxience: cómo es el laboratorio argentino que va a producir la vacuna de la Universidad de Oxford y AstraZeneca para América Latina

+

News Inmunova Top Story

ANMAT aprobó estudio clínico en humanos para el suero anti-Covid-19

+

News Grupo Insud

La OPS selecciona centros en Argentina y Brasil para desarrollar vacunas de ARNm contra la COVID-19

+

News Grupo Insud

INSUD cierra deal con Moolec

+